Compositions and kits for treating influenza
作者： David Chernoff , Paul Spence , Terry L. Burkoth , Mickey S. Urdea , Timothy J. Fultz
DOI:
关键词:
摘要: Kits comprising an M2 inhibitor selected from amantadine and rimantadine; ribavirin, a neuraminidase (NAi) in amount that is antivirally effective the combination, oral dosage form containing 75-250 mg of inhibitor, 100-400 ribavirin are provided for treatment influenza. Some embodiments kits comprise inhibitor.
lens.org参考文章(58)
MG Ison, FG Hayden, R Steigbigel, S Nagy-Agren, C Paya, Jr Jw Gnann, M Elliott, J Treannor, HL Weiss, Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza. Antiviral Therapy. ,vol. 8, pp. 183- 190 ,(2003)
Kenneth G. Draper, Method and reagent for inhibiting influenza virus replication ,(1994)
Timothy J. Fultz, David Chernoff, Paul Spence, Terry L. Burkoth, Mickey S. Urdea, Rowan Chapman, Jack Nguyen, Gregory T. Went, Emergency Preparations for an Epidemic ,(2009)
J D Connor, F G Hayden, J Lane, C A Sable, Intravenous ribavirin by constant infusion for serious influenza and parainfluenzavirus infection. Antiviral Therapy. ,vol. 1, pp. 51- 56 ,(1996)
Lisa M. Johansen, Christopher M. Owens, Compositions and methods for treatment of viral diseases ,(2009)
Stephan Pleschka, Stephan Ludwing, Hans-Harald Sedlacek, Oliver Planz, Use of active ingredients for the prophylaxis and/or therapy of viral diseases ,(2004)
David J. Grampovnik, Malken Bayrakdarian, Yu Gui Gu, Steven W. Muchmore, Yuanwei Chen, April Kennedy, Yibo Xu, Xuehong Luo, Kent D. Stewart, Gary T. Wang, Vincent L. Giranda, Hing L. Sham, Frank L. Wagenaar, Noah P. Tu, Paul E. Wiedeman, Stephen Hanessian, Warren M. Kati, David A. Degoey, Darold L. Madigan, Vincent S. Stoll, Allan C. Krueger, Chen Zhao, Hui-Ju Chen, Dale J. Kempf, Larry L. Klein, Keith F. McDaniel, Ming C. Yeung, Sheldon Wang, Minghua Sun, William J. Flosi, Clarence J. Maring, Zhen Lin, Inhibitors of neuraminidases ,(2000)
Stephan Pleschka, Stefan Ludwig, Hans-Harald Sedlacek, Oliver Planz, Caspase inhibitors, especially caspase 3 inhibitors, for the treatment of influenza ,(2004)
Joaquina Faour, Juan A. Vergez, Drug delivery device containing oseltamivir and an H1 antagonist ,(2001)
Raymond F. Schinazi, Craig L. Hill, Method compositions and apparatus for treating and preventing respiratory viral infections ,(1995)